Metformin Hydrochloride Extended-Release Tablet Recall
Three Metformin Drug Manufacturers Recall Medication Due to Potential Carcinogen WASHINGTON, D.C. — The U.S. Food and Drug (FDA) administration announced that three drug manufacturers initiated voluntary recalls of its metformin medication due to the presence of a potential human carcinogen. The Miami Herald identified the three … [Read more...] about Metformin Hydrochloride Extended-Release Tablet Recall
